background
highli
pathogen
human
coronaviru
caus
respiratori
diseas
emerg
middl
east
region
inhous
molecular
diagnost
method
viru
term
middl
east
respiratori
syndrom
coronaviru
merscov
allow
sensit
merscov
rna
detect
patient
sampl
fast
diagnosi
import
manag
human
case
trace
possibl
contact
object
aim
studi
improv
avail
exist
nucleic
acid
amplificationbas
diagnost
method
merscov
infect
provid
realtim
rtpcr
kit
includ
intern
control
two
target
region
recommend
world
health
organ
valid
kit
realstar
merscov
rtpcr
kit
altona
diagnost
gmbh
hamburg
germani
use
clinic
sampl
one
merscov
case
munich
respiratori
sampl
patient
respiratori
diseas
studi
design
intern
amplif
control
includ
rtpcr
assay
target
genom
region
upstream
envelop
gene
upe
within
open
read
frame
orf
base
assay
readytous
realtim
rtpcr
kit
featur
upe
assay
develop
valid
compar
establish
inhous
version
result
perform
rtpcr
assay
includ
kit
compar
inhous
assay
show
high
analyt
sensit
upe
copiesreact
copiesreact
crossreact
respiratori
pathogen
detect
merscov
rna
patient
sampl
almost
manner
inhous
version
conclus
kit
valuabl
tool
assist
rapid
diagnosi
patient
manag
epidemiolog
suspect
merscov
case
middl
east
respiratori
syndrom
coronaviru
merscov
first
detect
singl
patient
sever
respiratori
tract
infect
saudi
arabia
evid
spread
provid
viru
detect
second
patient
qatar
treat
similar
symptom
unit
kingdom
sinc
increas
number
case
includ
fatal
case
notifi
world
health
organ
human
case
link
middl
east
region
import
case
also
detect
europ
africa
viru
detect
major
case
done
use
specif
realtim
reversetranscript
pcr
rrtpcr
assay
sampl
lower
respiratori
tract
sampl
upper
respiratori
tract
use
investig
mild
case
contact
despit
lower
viru
concentr
materi
two
rrtpcr
assay
previous
publish
group
recommend
merscov
molecular
diagnost
assay
target
genom
region
upstream
envelop
gene
upe
viral
open
read
frame
assay
prove
highli
sensit
success
use
identif
major
diagnos
mer
case
base
xaxi
show
input
rna
copi
per
reaction
rhomb
experiment
data
point
solid
line
repres
correspond
probit
curv
dash
line
confid
interv
upe
assay
realtim
rtpcr
assay
use
oligonucleotid
develop
readytous
reagent
formul
avail
test
kit
aim
studi
compar
inhous
version
upe
rrtpcr
analog
assay
includ
kit
target
loci
merscov
genom
kit
assay
simpl
workflow
increas
reliabl
pcr
result
contain
addit
heterolog
intern
amplif
system
control
gener
pcrinhibit
aim
determin
limit
detect
valid
kit
use
clinic
sampl
merscov
case
munich
germani
test
possibl
crossreact
respiratori
pathogen
protocol
inhous
assay
upe
assay
publish
previous
briefli
l
reaction
buffer
superscript
iii
onestep
rtpcr
system
invitrogen
karlsruh
germani
l
enzym
mixtur
addit
merscov
sequenc
inform
data
publicli
avail
januari
analys
variat
within
oligonucleotid
bind
site
could
neg
impact
pcrbase
viral
detect
fig
show
align
upe
target
region
variat
found
avail
sequenc
within
bind
region
primer
probe
limit
detect
realstar
merscov
rtpcr
upe
assay
determin
use
vitro
transcrib
rna
ivt
quantifi
spectrophotometri
ivt
dilut
halflogarithm
step
copiesreact
nucleasefre
water
contain
gml
carrier
rna
qiagen
hilden
germani
test
replic
n
posit
amplif
probit
regress
analysi
spss
ibm
ehningen
germani
use
determin
cutoff
valu
fig
upeassay
cutoff
valu
copiesreact
confid
interv
ci
copiesreact
assay
detect
copiesreact
probabl
ci
copiesreact
determin
sensit
detect
whole
viru
genom
rna
extract
l
input
l
elut
volum
cell
cultur
supernat
merscov
strain
grown
cell
serial
dilut
test
triplic
equival
plaqu
form
unit
pfu
reaction
assay
show
posit
triplic
result
pfureact
homogen
assay
sensit
inhous
assay
determin
analyt
specif
homogen
assay
perform
experi
exclud
nonspecif
signal
caus
human
nucleic
acid
nucleic
acid
respiratori
pathogen
patient
sampl
clinic
specimen
posit
respiratori
virus
test
kit
assay
clinic
sampl
contain
enteroviru
n
rhinoviru
n
human
parainfluenzaviru
n
n
n
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
human
cov
n
n
n
n
influenza
n
influenza
n
influenza
b
n
falseposit
result
obtain
merscov
assay
intern
amplif
control
detect
reaction
show
none
pcr
reaction
inhibit
nineteen
sampl
patient
test
inhous
upe
assay
compar
realstar
merscov
rtpcr
kit
tabl
among
sampl
eight
test
posit
seven
neg
assay
four
sampl
show
discrep
result
sampl
test
posit
kit
assay
test
posit
inhous
assay
formul
discrep
result
seen
sampl
low
viru
concentr
indic
high
ctvalu
shown
test
laboratorydefin
well
origin
clinic
materi
realstar
merscov
rtpcr
kit
compar
recommend
inhous
formul
term
sensit
specif
avail
homogen
assay
format
provid
test
kit
provid
import
benefit
gener
diagnost
laboratori
deal
request
investig
case
suspect
merscov
infect
handl
test
kit
straightforward
requir
mix
two
instead
seven
eight
differ
reagent
reduc
risk
human
error
prepar
vast
major
diagnost
investig
suspect
merscov
case
done
intent
rule
infect
realstar
assay
includ
second
heterolog
amplif
system
control
pcr
inhibit
gener
reaction
failur
convers
avail
two
differ
detect
target
includ
kit
great
util
posit
case
wherebi
first
step
confirmatori
test
achiev
result
second
target
gene
long
merscov
infect
rare
clinic
entiti
howev
diagnost
confirm
never
reli
result
one
test
alon
possibl
gener
error
laboratori
level
consid
time
clinic
sampl
case
posit
initi
result
forward
refer
laboratori
order
achiev
confirm
provid
refer
materi
sever
rare
infect
review
paper
merscov
sequenc
includ
target
gene
assay
becom
avail
align
new
sequenc
target
assay
show
mismatch
within
primerand
probe
bind
site
among
new
sequenc
upe
target
region
two
sequenc
show
singl
nucleotid
mismatch
includ
one
second
posit
upe
forwardprim
wadiaddawasir
sequenc
genbank
anoth
second
posit
upeprob
riyadh
sequenc
genbank
gener
vitrotranscrib
rna
contain
mismatch
encount
loss
sensit
use
inhous
well
kitbas
formul
upe
assay
author
cd
receiv
infrastructur
support
german
centr
infect
research
dzif
ttu
includ
full
fund
posit
author
vmc
requir
